BioAlg Corp. Alternatives & Competitors

12 companies similar to BioAlg Corp. — AI & ML in Cancer Biology

Day One Biopharmaceuticals

Cancer drug development comes of age.

190 Post-IPO Equity $687.50M

Brisbane, United States

Biopharma Biotechnology +2

Ancora.ai

Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer pat...

9 Grant $465.00K

Zurich, Switzerland

AI Big Data +3

Synamics Therapeutics

AI-powered therapeutics for treatment-resistant cancer

7 Seed $4.10M

Beverly Hills, United Sta...

Biotechnology Pharmaceutical

Lantern Pharma Inc. (Nasdaq: LTRN)

Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies

33 Post-IPO Secondary

Dallas, United States

AI Biopharma +3

Rival Readout

Competing with BioAlg Corp.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

SyntheticGestalt

Scientific Research by Artificially Intelligent Agents

20 $14.00M

London, Japan

Biotechnology Pharmaceutical

iOnctura

Developing precision small molecules to combat hard-to-treat tumors.

28 Series B $118.37M

Geneve, Switzerland

Biotechnology Health Care +2

MNM Bioscience

From tumor genomes to AI-driven drug discovery

2 Seed $2.01M

Cambridge, United States

AI Biotechnology +2

Insilico Medicine

#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLM...

286 IPO $764.50M

Boston, United States

AI Biotechnology +2

Photobiotics

Innovative solutions for precise MRI imaging and cancer treatment with advanced drug deliv...

1 Venture round $390.00K

Biotechnology Life Sciences +1

Massive Bio

AI-driven system connecting cancer patients to clinical trials in real time. Industrializi...

103 Series B $28.10M

Istanbul, Turkey

AI Big Data +5

Endocyte

16 Debt Financing $114.35M

West Lafayette, United St...

Biotechnology Health Care +1

Aummune

WE ARE ALL UNIQUE SO IS AUMMUNE. The future of personalized therapy for cancer

Israel

Biotechnology Design +3

About BioAlg Corp.

BioAlg Corp. is a biotechnology, pharmaceutical, and SaaS startup headquartered in the United States. Founded in 2017, the company's mission revolves around machine learning and computational biology to advance cancer treatment and drug design.

Business keywords

AI-driven Platform, Clinical Trials Simulation, Machine Learning Algorithms, Cancer Treatment, Drug Design, Computational Biology, Digital Patient Modeling, Precision Medicine, Bioinformatics, Oncology, Molecular Effect Prediction, Clinical Trial Optimization, Biotech Innovation

Frequently Asked Questions

Companies similar to BioAlg Corp. include Day One Biopharmaceuticals, Ancora.ai, Synamics Therapeutics, Lantern Pharma Inc. (Nasdaq: LTRN), SyntheticGestalt. They work in Biotechnology and Pharmaceutical and share BioAlg Corp.'s focus on precision medicine, cancer treatment and oncology.

Bounce Watch lists 12 companies that share BioAlg Corp.'s industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around BioAlg Corp.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

BioAlg Corp. Profile Day One Biopharmaceuticals Alternatives Ancora.ai Alternatives Synamics Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at BioAlg Corp. on 13 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.